Unintended effects of statins

yellow card reports add data

Katherine Davidson, Sheena Kerr, Moira Kinnear, D Nicholas Bateman

Research output: Contribution to journalLetter

Abstract

Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.
Original languageEnglish
Article numberc3697
JournalBritish Medical Journal
Volume341
DOIs
Publication statusPublished - 13 Jul 2010

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pharmaceutical Preparations
Potassium Sparing Diuretics
Mineralocorticoid Receptor Antagonists
Sodium Potassium Chloride Symporter Inhibitors
Renin-Angiotensin System
Anti-Inflammatory Agents
Retrospective Studies
Delivery of Health Care
Kidney
Lipids

Keywords

  • yellow card data
  • lipid lowering drugs
  • nephrotoxins
  • statins

Cite this

Davidson, K., Kerr, S., Kinnear, M., & Bateman, D. N. (2010). Unintended effects of statins: yellow card reports add data. British Medical Journal, 341, [c3697]. https://doi.org/10.1136/bmj.c3697
Davidson, Katherine ; Kerr, Sheena ; Kinnear, Moira ; Bateman, D Nicholas. / Unintended effects of statins : yellow card reports add data. In: British Medical Journal. 2010 ; Vol. 341.
@article{fb4805d101f34511bced44d5f1b3cd7f,
title = "Unintended effects of statins: yellow card reports add data",
abstract = "Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.",
keywords = "yellow card data , lipid lowering drugs, nephrotoxins, statins",
author = "Katherine Davidson and Sheena Kerr and Moira Kinnear and Bateman, {D Nicholas}",
year = "2010",
month = "7",
day = "13",
doi = "10.1136/bmj.c3697",
language = "English",
volume = "341",
journal = "BMJ",
issn = "0959-8138",

}

Unintended effects of statins : yellow card reports add data. / Davidson, Katherine; Kerr, Sheena; Kinnear, Moira; Bateman, D Nicholas.

In: British Medical Journal, Vol. 341, c3697, 13.07.2010.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Unintended effects of statins

T2 - yellow card reports add data

AU - Davidson, Katherine

AU - Kerr, Sheena

AU - Kinnear, Moira

AU - Bateman, D Nicholas

PY - 2010/7/13

Y1 - 2010/7/13

N2 - Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.

AB - Like Hippisley-Cox and Coupland,1 our retrospective study using yellow card data submitted to the Medicines and Healthcare products Regulatory Agency (MRHA) from 2002 to 2006 found that lipid lowering drugs are often reported in association with drug induced renal toxicity. They came third after recognised nephrotoxins such as non-steroidal anti-inflammatory drugs and drugs acting on the renin-angiotensin system and ahead of loop diuretics, potassium sparing diuretics, and aldosterone antagonists.

KW - yellow card data

KW - lipid lowering drugs

KW - nephrotoxins

KW - statins

U2 - 10.1136/bmj.c3697

DO - 10.1136/bmj.c3697

M3 - Letter

VL - 341

JO - BMJ

JF - BMJ

SN - 0959-8138

M1 - c3697

ER -